1 completed, 1 withdrawn. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
| Phase 1 | 1 | Withdrawn 1 |
Follow cannabichromene: new trials by email Literature Review of cannabichromene trials Research Report on cannabichromene
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cannabichromene Safety in Rheumatoid Arthritis Cannabichromene - Arthritis, Rheumatoid | Phase 1 / Phase 2 | Withdrawn | Crystal Lederhos Smith | 2028-07-15 | 2026-09-23 | |
| Unique Treatment of Oncology Pain in Advanced Cancer Trichomylin® capsule (5 mg delta-9-tetrahydrocannabinol: 5 mg cannabidiol: 5 mg cannabichromene) - Cancer Pain | Phase 2 | Completed | ZYUS Life Sciences Inc. | 11 | 2025-06-12 | 2026-09-01 |
Arthritis, Rheumatoid (1) · Cancer Pain (1)
Crystal Lederhos Smith (1) · ZYUS Life Sciences Inc. (1)
Canada (1) · United States (1)
Crystal L Smith, PhD (1) · Julie Stakiw, MD (1)